List Of Contact Lenses And Solutions For Contact Lenses Approved From MoPH

List of Contact Lenses and Solutions for Contact Lenses Approved from MoPH

MOH requirements for registration of contact lenses /solution registration

An authorized free sale certificate or CFG describing the classification of the product in its country of origin (medical devices.._) with the manufacturer and product name , stamped from :

Chamber of commerce in the country of origin
The Lebanese embassy in the country of origin

ISO 1385
EU MDR certificates OR CE extended (file to be submitted at diwan )
Methods of sterilization
2 samples of the product in their final form as they are going to be sold in the market or mock up
A long term stability data on one batch number for the whole product shelf-life mentioning batch size, manufacturer data and batch number (for solutions only )
Storage conditions
Summary of product characteristics

MOH requirements for importation of contact lenses /solution registration

Same requirements of importation of sterile items.

List of Contact Lenses and Solutions for Contact Lenses Approved from MoPH

...

175

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N03AX18	TREPADIO	G	Lacosamide - 200mg	200mg	Tablet, film coated	8,876,013 L.L
N03AX18	TREPADIO	G	Lacosamide - 10mg/ml	10mg/ml	Syrup	948,753 L.L
N03AX18	TREPADIO	G	Lacosamide - 200mg/20ml	200mg/20ml	Injectable solution	9,569,390 L.L
A10AE06	TRESIBA	BioTech	Insulin degludec - 100IU/ml	100IU/ml	Injectable solution	6,223,335 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.05%	0.05%	Solution	623,287 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.025%	0.025%	Solution	564,414 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.1%	0.1%	Solution	682,160 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	35,006,803 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	40,713,289 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	50,113,451 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	75,169,610 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 500mg, Lidocaine - 1%	500mg	Injectable powder for solution+diluent	356,118 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 1g, Lidocaine - 1%	1g	Injectable powder for solution+diluent	438,093 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	4,542,188 L.L
L04AA29	TRIJAN	G	Tofacitinib - 5mg	5mg	Tablet, film coated	54,863,315 L.L
L04AA29	TRIJAN	G	Tofacitinib - 10mg	10mg	Tablet, film coated	84,793,962 L.L
A11DB	TRILAGAVIT	G	Vitamin B12 - 1mg, Vitamin B6 - 100mg, Vitamin B1 - 200mg		Tablet, film coated	399,121 L.L
A11DB	TRILAGAVIT	G	Vitamin B12 - 1mg/3ml, Vitamin B6 - 100mg/3ml, Vitamin B1 - 100mg/3ml		Injectable solution	579,196 L.L
S01GA52	TRILLERG	G	Antazoline HCl - 0.5mg, Tetryzoline HCl - 0.4mg		Drops solution	310,428 L.L
C09AA05	TRILTEC	G	Ramipril - 1.25mg	1.25mg	Capsule	524,739 L.L
C09AA05	TRILTEC	G	Ramipril - 2.5mg	2.5mg	Capsule	255,970 L.L
C09AA05	TRILTEC	G	Ramipril - 5mg	5mg	Capsule	447,948 L.L
C09AA05	TRILTEC	G	Ramipril - 10mg	10mg	Capsule	575,933 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 10mg, Hydrochlorothiazide - 12.5mg		Tablet	2,243,577 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 5mg, Hydrochlorothiazide - 12.5mg		Tablet	2,189,823 L.L
R05X	TRIMEDIL FORTE	G	O-(ß-hydroxyethyl)-rutosides - 30mg, Ascorbic acid - 80mg, Dimethindene - 0.5mg, Phenylephrine HCl - 2.5mg, Paracetamol - 200mg		Capsule	386,515 L.L
C01DA02	TRINITRINA	G	Nitroglycerine - 50mg/50ml	50mg/50ml	Injectable concentrate for solution	6,212,584 L.L

...

175

...